Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX7ILB
|
||||
| Drug Name |
6-(4-Methylsulfanyl-phenyl)-1,2,3,5,6,10b-hexahydro-pyrrolo[2,1-a]isoquinoline
|
||||
| Synonyms |
CHEMBL2114391
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H21NS
|
||||
| Canonical SMILES |
[11CH3]Sc1ccc(cc1)[C@@H]2CN3CCC[C@@H]3c4ccccc24
|
||||
| InChI |
InChI=1S/C19H21NS/c1-21-15-10-8-14(9-11-15)18-13-20-12-4-7-19(20)17-6-3-2-5-16(17)18/h2-3,5-6,8-11,18-19H,4,7,12-13H2,1H3/t18-,19+/m0/s1/i1-1
|
||||
| InChIKey |
YVKDUIAAPBKHMJ-AANZQFEOSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.